AptarGroup, Inc. (ATR)

NASDAQ

$122.34

+$0.87 (0.72%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$120.55$122.46

Open $121.48

52 Week Range

$103.23$170.93

Previous Close $121.47

Market Cap8.09B

Volume427.14K

Avg Volume555.98K

P/E (TTM)19.25

EPS (TTM)$6.36

Dividend / Yield$1.83 (1.50%)

Dividend Streak32 years

Latest Press Releases for AptarGroup, Inc.

DEC42025

Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year

Source: Business Wire•11 days ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year....

NOV112025

Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

Source: Business Wire•34 days ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025....

OCT302025

Aptar Reports Third Quarter 2025 Results

Source: Business Wire•46 days ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2025 Results....

OCT272025

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference

Source: GlobeNewsWire•49 days ago

VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at the AACR-NCI-EORTC International Confere...

SEP162025

CytoSorbents Provides DrugSorb-ATR Regulatory Update

Source: PRNewsWire•90 days ago

PRINCETON, N.J. , Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory u...